Omega-3 and renal function in older adults

Current Pharmaceutical Design

Volumn 15, Issue 36, 2009, Pages 4149-4156

  Lauretani, F ^a   Maggio, M ^a   Pizzarelli, F ^b   Michelassi, S ^b   Ruggiero, C ^c   Ceda, G P ^a   Bandinelli, S ^d   Ferrucci, L ^e  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Azienda Sanitaria di Firenze   (Italy)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Chronic kidney disease; Chronic renal failure; Polyunsaturated fatty acids; Renal function

Indexed keywords

CHOLESTEROL; CREATININE; CYTOKINE; DOCOSAHEXAENOIC ACID; ENDOTHELIUM DERIVED RELAXING FACTOR; FISH OIL; FREE RADICAL; ICOSANOID; ICOSAPENTAENOIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; SOYBEAN OIL; TRIACYLGLYCEROL; VEGETABLE OIL;

AGING; ANTIINFLAMMATORY ACTIVITY; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CREATININE CLEARANCE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY INTAKE; DIETARY REFERENCE INTAKE; DRUG EFFICACY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FISH; GLOMERULOSCLEROSIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOSTASIS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; OBSTRUCTIVE UROPATHY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGING; CREATININE; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; ITALY; KIDNEY FAILURE, CHRONIC; WORLD HEALTH;

EID: 71849098441     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789909719     Document Type: Review

References (85)

1. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332: 563-564
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
3. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296 (Pubitemid 43228342)
4. Pizzarelli F. Lauretani F, Bandinelli S, Windham GB, Corsi AM, Giannelli SV, et al. Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transplant 2009; 24: 1197-1205
5. Goyal VK. Changes with age in the human kidney. Exp Gerontol 1982; 17: 321-331
6. Silva FG. The aging kidney: a review - Part I. Int Urol Nephrol 2005; 37: 185-205.
7. Silva FG. The aging kidney: a review - Part II. Int Urol Nephrol 2005; 37: 419-432
8. Clark B. Biology of renal aging in humans. Adv Renal Replace Ther 2000; 7: 11-21.
9. Baylis C. The aging kidney. Nephrology 1997; 15: 178-186
10. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996; 7: 1106-1122
11. Lindeman RD. Renal physiology and pathophysiology of aging. Contrib Nephrol 1993; 105: 1-12.
12. Owen RA, Heywood R. Age-related variations in renal structure and function in Sprague-Dawley rats. Toxicol Pathol 1986; 14: 158-167 (Pubitemid 16016980)
13. Hirokawa K. Characterisation of age-associated kidney disease in Wistar rats. Mech Ageing Dev 1975; 4: 301-316
14. McDermott GF, Ingram A, Scholey J, Kirkland JL, Whiteside CL. Glomerular dysfunction in the aging Fischer 344 rat is associated with excessive growth and normal mesangial cell function. J Gerontol A Biol Sci Med Sci 1996; 51: M80-5. (Pubitemid 26088402)
15. Bolton WK, Sturgill BC. Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. II. Ultrastructural studies. Am J Pathol 1980; 98: 339-356
16. Davies I, Fotheringham AP, Faragher BE. Age-associated changes in the kidney of the laboratory mouse. Age Ageing 1989; 18: 127-133 (Pubitemid 19206289)
17. Yumura W, Sugino N, Nagasawa R, Kubo S, Hirokawa K, Maruyama N. Age-associated changes in the renal glomeruli of mice. Exp Gerontol 1989; 24: 237-249 (Pubitemid 19154169)
18. Nishida E, Yamanouchi J, Ogata S, Itagaki S, Doi K. Age-related histochemical and ultrastructural changes in renal glomerular mesangium of APA hamsters. Exp Anim 1996; 45: 339-345 (Pubitemid 126419654)
19. Finco DR, Brown SA, Crowel WA. Effects of aging and dietary protein intake on uninephrectomized geriatric dogs. Am J Vet Res 1994; 55: 1282-1290
20. Pugliese A, Grumpily A, Di Pietro S. Clinical nutrition in gerontology: chronic renal disorders of the dog and cat. Vet Res Commun 2005; 29 (Suppl 2): 57-63. (Pubitemid 41631364)
21. Hediger MA. Kidney function: gateway to a long life? Nature 2002; 417: 393-395
22. Lonergan ET. Aging and the kidney: adjusting treatment to physiologic change. Geriatrics 1988; 43: 27-30.
23. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine in man: a cross sectional and longitudinal study. J Gerontol 1976; 31: 155-163
24. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic renal disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12. (Pubitemid 36043346)
25. Locatelli F, Pozzoni P. Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int 2006; 69: 2118-2120
26. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of different races. Gerontologica 1971; 17: 87-97.
27. Griffiths GJ, Robinson KB, Cartwright GO, McLachlan MS. Loss of renal tissue in the elderly. Br J Radiol 1976; 49: 111-117
28. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N. The thickness of the renal parenchyma decreases with age: a CT study of 360 patients. Am J Roentgenol 1990; 155: 541-544 (Pubitemid 20254498)
29. Piepsz A. New renal scarring and age. Nucl Med Commun 2001; 22: 1273-1275
30. Kappel B, Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal kidney, related to age and sex. A quantitative study. Virchow Archiv A 1980; 387: 271-277
31. Lauks SP Jr, McClachlan MS. Aging and simple cysts of the kidney. Br J Radiol 1981; 54: 12-14
32. Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney. Exp Gerontol 1986; 21: 379-406. (Pubitemid 17215629)
33. Takizawa T, Takasaki I, Shionoiri H, Ishii M. Progression of glomerulosclerosis, renal hypertrophy, and an increased expression of fibronectin in the renal cortex associated with aging and salt-induced hypertension in Dahl salt-sensitive rats. Life Sci 1997; 61: 1553-1558 (Pubitemid 27425272)
34. Gagliano N, Arioso B, Santanbrogio B, Balestrieri MR, Padoani G, Taqliabue J, et al. Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex. J Gerontol A Biol Sci Med Sci 2000; 55: 365-372 (Pubitemid 32009013)
35. Ruiz-Torres MP, Bosch RJ, O'Valle F, Del Moral RG, Ramirez C, Masseroli M. Age-related increase in expression of TGF-1 in the rat kidney: relationship to morphological changes. J Am Soc Nephrol 1998; 54: 438-447 (Pubitemid 28209087)
36. Bailey AJ, Paul RG, Knott L. Mechanism of maturation and ageing of collagen. Mech Ageing Dev 1998; 106: 1-56.
37. Abrass CK, Adcox MJ, Raugi GJ. Age-associated changes in renal extracellular matrix. Am J Pathol 1985; 146: 742-752
38. Reckelhoff JF, Baylis C. Proximal tubular metalloprotease activity is decreased in the senescent rat kidney. Life Sci 1992; 50: 959-963
39. Tanaka T, Kato H, Kojima I, Ohse T, Son D, Tawakami, et al. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J Gerontol A Biol Sci Med Sci 2006; 61: 795-805. (Pubitemid 44260161)
40. Nath KA. Tubulo-interstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1.
41. Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80: 227-234
42. Neugarten J, Gallo G, Sibiger S, Kasiske B. Glomerulosclerosis in aging humans is not influenced by gender. Am J Kidney Dis 1999; 34: 884-888 (Pubitemid 29521705)
43. Newbold KM, Sandison AM, Howie AJ. Comparison of size of juxtaglomerular and outer cortical glomeruli in normal adult kidney. Virchow Archiv A Pathol Anat 1992; 420: 127-129
44. Charles Jeanette J, Olson JL, Schwartz MM, Silva FG, Eds. Heptinstall's Pathology of the Kidney (5th ed). Philadelphia, New York: Lippincott-Raven 1998.
45. Howie AJ, Kizaki T, Beaman M, Morland CM, Birtwistle RJ, Adu D, et al. Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria. J Pathol 1989; 157: 141-145 (Pubitemid 19061408)
46. Brenner BM. Nephrology forum: hemodynamically mediated glomerular injury and the progressive nature of renal disease. Kidney Int 1983; 23: 647-655
47. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986; 80: 435-442
48. Nakano M, Ito Y, Kohtani K, Mizuno T, Tauchi H. Age-related change in brush borders of rat kidney cortex. Mech Ageing Dev 1985; 33: 95-102. (Pubitemid 16206494)
49. Sato T, Tauchi H. Age changes of mitochondria of rat kidney. Mech Ageing Dev 1982; 20: 111-126 (Pubitemid 13220049)
50. Gaubatz JW, Tan BH. Aging affects the levels of DNA damage in postmitotic cells. Ann NY Acad Sci 1994; 719: 97-107. (Pubitemid 24199968)
51. Pelletier J, Desrosiers RR, Beliveau R. Age-related changes in carboyl methylation of proteins in the kidney. Mech Ageing Dev 1996; 86: 115-135 (Pubitemid 26069349)
52. Percy C, Pat B, Poronnik P, Gobe G. Role of oxidative stress in age-associated chronic kidney pathologies. Adv Chron Kidney Dis 2005; 12: 78-83. (Pubitemid 40255607)
53. Goldman L, Bennett JC. Cecil Handbook of Medicine, 21st Ed. Philadelphia, W.B. Saunders Co 2000; p. 573.
54. Remuzzi G, Ruggenenti P. Overview of randomised trials of ACE inhibitors. Lancet 2006; 368: 555-556 (Pubitemid 44188863)
55. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-269
56. Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994; 331: 1194-1199
57. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748
58. Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001; 12: 791-799
59. Donadio JV. n-3 Fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens 2001; 10: 639-642 (Pubitemid 32783814)
60. Grande JP, Walker HJ, Holub BJ, Warner GM, Keller DM, Haugen JD, et al. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 2000; 57: 1027-1040 (Pubitemid 30434792)
61. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension.Eur J Clin Nutr 2004; 58: 195-203.
62. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J Am Soc Nephrol 2003; 14: 389-396
63. de Jonge HW, Dekkers DH, Lamers JM.Polyunsaturated fatty acids and signalling via phospholipase C-beta and A2 in myocardium. Mol Cell Biochem 1996; 157: 199-210.
64. Lauretani F, Semba RD, Bandinelli S, Miller ER 3rd, Ruggiero C, Cherubini A et al. Plasma polyunsaturated fatty acids and the decline of renal function. Clin Chem 2008; 54: 475-481 (Pubitemid 351348158)
65. Simopoulos AP, Leaf A, Salem N Jr. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000; 63: 119-121 (Pubitemid 30828789)
66. Kapoor R, Huang YS. Gamma linolenic acid: an anti-inflammatory omega-6 fatty acid. Curr Pharm Biotechnol 2006; 7: 531-534 (Pubitemid 46017544)
67. Zatonski WA, Willett W. Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ 2005; 331: 187-188 (Pubitemid 41039798)
68. Calviello G, Serini S, Piccioni E.n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved.Curr Med Chem 2007; 14: 3059-3069
69. Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 2006; 1: 182-192
70. Lim AK, Manley KJ, Roberts MA, Fraenkel MB. Fish oil for kidney transplant recipients. Cochrane Database Syst Rev 2007; 2: CD005282.
71. Locatelli F, Vecchio LD, Pozzi C. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors. Nat Clin Pract Nephrol 2006; 2: 24-31. (Pubitemid 43355242)
72. Wolk A, Larsson SC, Johansson JE, Ekman P.Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA 2006; 296: 1371-1376 (Pubitemid 44427423)
73. Colin DF. Prostaglandines and leukotrienes: advances in eicosanoid biology. Science 2001; 294: 1871-1875
74. Torrejon C, Jung UJ, Deckelbaum RJ. n-3 Fatty acids and cardiovascular disease: Actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 319-326 (Pubitemid 350198858)
75. Schlondorff D. Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 1993; 44: 643-653 (Pubitemid 23265236)
76. Shimokawa H, Vanhoutte PM. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. Circulation 1988; 78: 1421-1430 (Pubitemid 19004244)
77. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446 (Pubitemid 43236907)
78. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757 (Pubitemid 35364932)
79. Svensson M, Christensen JH, Sølling J, Schmidt EB. The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis 2004; 44: 77-83. (Pubitemid 38880930)
80. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-533 (Pubitemid 23228051)
81. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65: 1645S-54.
82. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17: 279-286 (Pubitemid 27098185)
83. Dieterle F, Marrer E, Suzuki E, Grenet O, Cordier A, Vonderscher J. Monitoring kidney safety in drug development: emerging technologies and their implications. Curr Opin Drug Discov Devel 2008; 11(1): 60-71.
84. Fukami K, Yamagishi S, Ueda S, Okuda S. Role of AGEs in diabetic nephropathy. Curr Pharm Des 2008; 14(10): 946-952
85. Paraskevas KI, Mikhailidis DP, Thompson CS. Experimental models for the study of drugs used to prevent and treat vascular diseases. Curr Pharm Des 2008; 14(4): 306-308